The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults
- 110 Downloads
Objectives:To investigate the relationship between lipodystrophy-specific symptom severity and wellbeing. Methods:HIV-positive adult patients with body fat redistribution (lipodystrophy syndrome) associated with antiretroviral therapy reported their total non-lipodystrophy symptoms and side effects and completed measures assessing body fat changes (yielding Atrophy, Hypertrophy and Total Lipodystrophy scores), mental health and quality of life. Effects of total symptom complex and lipodystrophy severity on quality of life and mental health were analyzed using Spearman’s rho correlations. Logistic regression analyses were utilized to determine the relative-odds of depression produced by overall symptom count and lipodystrophy score increments. Results:Mean ratings for Hypertrophy and Atrophy corresponded to ‘very mild’ and ‘mild’ degrees of severity, respectively. The total symptom complex was associated with ratings for most of the mental health and quality of life measures. Patient-perceived body image scores were the sole study variable responsive to lipodystrophy severity ratings. In comparison to reference norms, a pronounced degree of body image impairment was evident. Conclusion: Although responsive to the total symptom profile, psychosocial measures typically utilized for evaluating quality of life and mental health status in HIV disease lacked sensitivity and specificity for measuring the consequences of lipodystrophy-associated fat distribution changes alone. Lipodystrophy severity did impact negatively on body image.
KeywordsBody image HIV Lipodystrophy Mental health Quality of life
Unable to display preview. Download preview PDF.
- 6.Murri, R, Ammassari, A, Fantoni, M, Scoppettuolo, G. 1997Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV health surveyJ AIDS Hum Retrovirol16350356Google Scholar
- 13.Schambelan, M, Benson, C, Carr, A, Currier, J, Dube, M, Gerber, J, et al. 2002Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA panelJ AIDS31257275Google Scholar
- 16.Bassetti, S, Battegay, M, Furrer, H, Rickenback, M, Flepp, M, Kaiser, L 1999Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?J AIDS21114119Google Scholar
- 20.Oette, M, Juretzko, P, Kroidl, A, Sagir, A, Wettstein, M, Siegrist, J, et al. 2002Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patientsAIDS Patient Care16413417Google Scholar
- 26.Justice, A, Rabeneck, L, Hays, R, Wu, A, Bozzette, S. 1999Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptomsJ AIDS21126133Google Scholar
- 32.Spielberger, C, Gorsuch, R, Lushene, R, Vagg, P, Jacobs, G. 1983State-Trait Anxiety Inventory for AdultsMind Garden Inc.Palo Alto CAGoogle Scholar
- 33.Rosenberg, M. 1965Society and the Adolescent Self-ImagePrinceton University PressPrinceton NJGoogle Scholar
- 34.Beck A, Steer R, Brown G. BDI -II Manual for Beck Depression Inventory, 2nd edition, San Antonio, TX: The Psychological Corporation (Harcourt Brace & Co.), 1996.Google Scholar